Type 2 Diabetes Increases Risk for Hepatic Decompensation, HCC in NAFLD
The likelihood of developing hepatic decompensation and hepatocellular carcinoma is higher among patients with NAFLD and type 2 diabetes.
Lancet Gastroenterology Cochrane Central Register Controlled Trials Cochrane Data Systematic Reviews
Source: endocrinologyadvisor.com